Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 22(8)2021 Apr 09.
Article in English | MEDLINE | ID: mdl-33918885

ABSTRACT

The appearance of uracil in the deoxyuridine moiety of DNA is among the most frequently occurring genomic modifications. Three different routes can result in genomic uracil, two of which do not require specific enzymes: spontaneous cytosine deamination due to the inherent chemical reactivity of living cells, and thymine-replacing incorporation upon nucleotide pool imbalances. There is also an enzymatic pathway of cytosine deamination with multiple DNA (cytosine) deaminases involved in this process. In order to describe potential roles of genomic uracil, it is of key importance to utilize efficient uracil-DNA detection methods. In this review, we provide a comprehensive and critical assessment of currently available uracil detection methods with special focus on genome-wide mapping solutions. Recent developments in PCR-based and in situ detection as well as the quantitation of genomic uracil are also discussed.


Subject(s)
DNA , Genome , Uracil , Animals , DNA/chemistry , DNA/metabolism , DNA Repair , DNA Replication , Genetic Testing , Genome-Wide Association Study , High-Throughput Nucleotide Sequencing , Humans , In Situ Hybridization , Nucleotides , Polymerase Chain Reaction , Signal Transduction , Uracil/chemistry , Uracil/metabolism , Uracil-DNA Glycosidase/metabolism
2.
Elife ; 92020 09 21.
Article in English | MEDLINE | ID: mdl-32956035

ABSTRACT

Numerous anti-cancer drugs perturb thymidylate biosynthesis and lead to genomic uracil incorporation contributing to their antiproliferative effect. Still, it is not yet characterized if uracil incorporations have any positional preference. Here, we aimed to uncover genome-wide alterations in uracil pattern upon drug treatments in human cancer cell line models derived from HCT116. We developed a straightforward U-DNA sequencing method (U-DNA-Seq) that was combined with in situ super-resolution imaging. Using a novel robust analysis pipeline, we found broad regions with elevated probability of uracil occurrence both in treated and non-treated cells. Correlation with chromatin markers and other genomic features shows that non-treated cells possess uracil in the late replicating constitutive heterochromatic regions, while drug treatment induced a shift of incorporated uracil towards segments that are normally more active/functional. Data were corroborated by colocalization studies via dSTORM microscopy. This approach can be applied to study the dynamic spatio-temporal nature of genomic uracil.


Subject(s)
Antineoplastic Agents/pharmacology , DNA , Genome , Uracil , DNA/analysis , DNA/biosynthesis , DNA/chemistry , DNA/genetics , Genome/drug effects , Genome/genetics , Genomics , HCT116 Cells , Humans , Microscopy , Sequence Analysis, DNA , Uracil/analysis , Uracil/biosynthesis , Uracil/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...